[DOI] [PMC free article] [PubMed] [Google Scholar] 299.Touvier M, da Costa Louzada ML, Mozaffarian D, Baker P, Juul F, Srour B
GLP-1 receptor agonists (GLP-1RAs) are well established for glycemic control and weight reduction in patients with type 2 diabetes mellitus (T2DM) and/or obesity and have demonstrated cardiovascular benefit [2]
New offerings include expanded pharmacy support designed to help patients access these treatments and stay on them, and a new $49 MinuteClinic virtual visit that connects eligible adults with licensed clinicians who can evaluate and, where clinically appropriate, prescribe GLP-1 therapy
Perimenopause encompasses the years from a womans first irregular period up to 12 months after their final period
The definition of injection site reactions in clinical trials typically includes pain, erythema, pruritus, and other local symptoms that patients report to investigators